leisure time -WSS

leisure time

author：comprehensive 2025-09-30 01:15:02 - browse：742

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： How climate

Wikipedia

knowledge

WSS

To bolster infectious disease surveillance, genomics powerhouses team up

A pediatrician calls for Congress to pass the child tax credit deal

STAT Summit: Biotech founders on deal

Studies point to risks of excluding people with obesity from drug trials

Mass General, Mayo Clinic look to monetize custom

STAT Summit: GSK CEO on pharma giant's new direction

entertainment

leisure time

focus

As demand for Covid shots wanes, Moderna seeks its next success

Microsoft launches AI tool for clinical documentation through Epic

23andMe had bad news about my health. I wish a person had delivered it

STAT Summit: How a Chicago ER doctor tackles gun violence

Dobbs anniversary: the lost opportunity of abortion as health care

Eli Lilly expects to double planned employment in Boston center

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA gives detailed accounting of AI

Sports medicine is finally prioritizing gender equality

Medicare bonuses could stop drug shortages under Senate plan

explore

Prior authorization reform is both possible and imperative

STAT Summit: Biotech founders on deal

Inaction leaves children at risk from dangerous chemotherapy drug

STAT Summit: GSK CEO on pharma giant's new direction

Prior authorization reform is both possible and imperative

UnitedHealth’s board chair also owns a personal investment firm

Wikipedia

hotspot

knowledge

hotspot